Sigma Healthcare Ltd operates in the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sigma Healthcare Ltd with three other drug stores in Australasia: Ecofibre Ltd (2021 sales of 28.79 million Australian Dollars [US$20.86 million] of which 50% was Ananda Health), Medical Developments International Ltd (25.34 million Australian Dollars [US$18.36 million] of which 77% was Pharmaceuticals), and McPherson's Limited (200.77 million Australian Dollars [US$145.49 million] ).

Sales Analysis. During the second fiscal quarter of 2022, sales at Sigma Healthcare Ltd totalled A$1.79 billion. This is an increase of 5.6% from the A$1.69 billion in sales at the company during the second quarter of 2021. Sigma Healthcare Ltd reported sales of A$3.51 billion (US$2.54 billion) for the fiscal year ending January of 2021. This represents an increase of 5.0% versus 2020, when the company's sales were A$3.34 billion. Despite this increase, sales are still well below the level achieved in 2019, when Sigma Healthcare Ltd reported sales of A$4.08 billion. The sales level in 2021 was fairly close to the level five years ago: in 2016, Sigma Healthcare Ltd had sales of A$3.53 billion.